Detailed information for compound 423915

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 262.301 | Formula: C15H18O4
  • H donors: 2 H acceptors: 3 LogP: 0.64 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1C2C[C@@H](O[C@@H]2[C@H](c2c1cccc2)O)C(O)(C)C
  • InChi: 1S/C15H18O4/c1-15(2,18)11-7-10-12(16)8-5-3-4-6-9(8)13(17)14(10)19-11/h3-6,10-11,13-14,17-18H,7H2,1-2H3/t10?,11-,13+,14+/m0/s1
  • InChiKey: BVAYYWKYGJBBHG-PJLFXZSHSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3702 0.3702
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0037 0.201 0.1204
Trypanosoma brucei target of rapamycin kinase 3, putative 0.007 0.7215 0.6934
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3702 0.3702
Plasmodium falciparum peptidyl-prolyl cis-trans isomerase FKBP35 0.0058 0.526 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3702 0.3702
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3713 0.3713
Loa Loa (eye worm) FKBP5 protein 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.007 0.7204 0.7204
Trichomonas vaginalis PIKK family atypical protein kinase 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3713 0.3713
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3713 0.3713
Echinococcus multilocularis peptidyl prolyl cis trans isomerase FKBP4 0.005 0.4031 0.3429
Echinococcus granulosus peptidyl prolyl cis trans isomerase FKBP4 0.005 0.4031 0.3429
Trichomonas vaginalis fk506-binding protein, putative 0.0058 0.526 0.526
Trichomonas vaginalis PIKK family atypical protein kinase 0.0075 0.8002 0.8002
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0088 1 1
Leishmania major peptidylprolyl isomerase-like protein 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0052 0.4418 0.4418
Trichomonas vaginalis immunophilin, putative 0.0058 0.526 0.526
Schistosoma mansoni immunophilin 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0053 0.4499 0.4499
Toxoplasma gondii target of rapamycin (TOR), putative 0.0066 0.6498 0.5
Plasmodium vivax 70 kDa peptidylprolyl isomerase, putative 0.0058 0.526 0.5
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0088 1 1
Schistosoma mansoni immunophilin 0.005 0.4031 0.3429
Schistosoma mansoni immunophilin 0.0058 0.526 0.4781
Trypanosoma cruzi peptidyl-prolyl cis-trans isomerase, putative 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0053 0.4499 0.4499
Loa Loa (eye worm) phosphatidylinositol 3 0.0088 1 1
Trypanosoma cruzi target of rapamycin kinase 3 0.007 0.7215 0.6934
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0916 0.0916
Echinococcus multilocularis peptidyl prolyl cis trans isomerase FKBP4 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0916 0.0916
Trichomonas vaginalis PIKK family atypical protein kinase 0.0052 0.4418 0.4418
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0916 0.0916
Brugia malayi FKBP-type peptidyl-prolyl cis-trans isomerase-12, BmFKBP-12 0.0058 0.526 0.4781
Trypanosoma brucei FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative 0.0058 0.526 0.4781
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0088 1 1
Echinococcus granulosus peptidyl prolyl cis trans isomerase FKBP4 0.0058 0.526 0.4781
Leishmania major fk506-binding protein 1-like protein 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0048 0.3713 0.3713
Echinococcus granulosus peptidyl prolyl cis trans isomerase FKBP1A 0.0058 0.526 0.4781
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0088 1 1
Loa Loa (eye worm) FKBP-type peptidyl-prolyl cis-trans isomerase-12 0.0058 0.526 0.4781
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0088 1 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.007 0.7204 0.7204
Trypanosoma brucei peptidyl-prolyl cis-trans isomerase, putative 0.0058 0.526 0.4781
Brugia malayi FKBP-type peptidyl-prolyl cis-trans isomerase-59, BmFKBP59 0.0058 0.526 0.4781
Trypanosoma cruzi FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0057 0.5205 0.5205
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0088 1 1
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0088 1 1
Echinococcus multilocularis fk506 binding protein 0.0058 0.526 0.4781
Trichomonas vaginalis peptidylprolyl isomerase, putative 0.0058 0.526 0.526
Trichomonas vaginalis PIKK family atypical protein kinase 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0059 0.5501 0.5501
Trichomonas vaginalis PIKK family atypical protein kinase 0.007 0.7204 0.7204
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0088 1 1
Trypanosoma cruzi peptidyl-prolyl cis-trans isomerase, putative 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0916 0.0916
Mycobacterium ulcerans FK-506 binding protein, peptidyl-prolyl cis-trans isomerase 0.0058 0.526 0.5
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0042 0.2796 0.207
Trichomonas vaginalis PIKK family atypical protein kinase 0.007 0.7204 0.7204
Schistosoma mansoni immunophilin FK506 binding protein FKBP12 0.0058 0.526 0.4781
Trichomonas vaginalis PIKK family atypical protein kinase 0.0053 0.4499 0.4499
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Trichomonas vaginalis PIKK family atypical protein kinase 0.007 0.7204 0.7204
Trichomonas vaginalis peptidylprolyl isomerase, putative 0.0058 0.526 0.526
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.007 0.7215 0.6934
Trypanosoma cruzi FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative 0.0058 0.526 0.4781
Giardia lamblia GTOR 0.0088 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0916 0.0916
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498
Loa Loa (eye worm) hypothetical protein 0.005 0.4031 0.3429
Trichomonas vaginalis PIKK family atypical protein kinase 0.0088 1 1
Treponema pallidum peptidyl-prolyl cis-trans isomerase, FKBP-type, 22 kDa (fklB) 0.0058 0.526 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0066 0.6498 0.6498

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.